Gallic acid-based indanone derivatives as anticancer agents

139Citations
Citations of this article
60Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Gallic acid-based indanone derivatives have been synthesised. Some of the indanones showed very good anticancer activity in MTT assay. Compounds 10, 11, 12 and 14 possessed potent anticancer activity against various human cancer cell lines. The most potent indanone (10, IC50 = 2.2 μM), against MCF-7, that is, hormone-dependent breast cancer cell line, showed no toxicity to human erythrocytes even at higher concentrations (100 μg/ml, 258 μM). While, indanones 11, 12 and 14 showed toxicities to erythrocytes at higher concentrations. © 2008 Elsevier Ltd. All rights reserved.

Cite

CITATION STYLE

APA

Saxena, H. O., Faridi, U., Srivastava, S., Kumar, J. K., Darokar, M. P., Luqman, S., … Khanuja, S. P. S. (2008). Gallic acid-based indanone derivatives as anticancer agents. Bioorganic and Medicinal Chemistry Letters, 18(14), 3914–3918. https://doi.org/10.1016/j.bmcl.2008.06.039

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free